{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009859","form_type":"8-K","ticker":null,"cik":"0001138978","company_name":"Novo Integrated Sciences, Inc.","filed_at":"2025-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.026415+00:00","generated_at":"2026-05-24T23:14:14.150297+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Novo Integrated Sciences extends CEO resignation to March 31, 2025; Mattacchione to stay as Chairman","bullets":["CEO Robert Mattacchione's resignation, previously set for February 5, 2025 and extended twice, now extended to no later than March 31, 2025.","After stepping down as CEO, Mattacchione will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Limited.","Resignation is not due to any disagreement with company operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009859","json":"https://secwatch.observer/filing/0001493152-25-009859.json","markdown":"https://secwatch.observer/filing/0001493152-25-009859.md","text":"https://secwatch.observer/filing/0001493152-25-009859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/0001493152-25-009859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T23:14:14.150297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2593f34883","claim":"Robert Mattacchione resigned as Chief Executive Officer at Novo Integrated Sciences, Inc..","evidence_excerpt":"Following Mr. Mattacchione’s departure as Chief Executive Officer, Mr. Mattacchione intends to continue to serve as (i) the Company’s Chairman of the Board, and (ii) Chairman of Novo Healthnet Limited, a wholly owned subsidiary of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1138978/000149315225009859/0001493152-25-009859-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}